The Catecholamine Response: Why Cold Feels Like a Drug
The most robust and well-replicated finding in cold exposure research is the catecholamine response. When the body is exposed to cold water (typically below 15°C/59°F), the sympathetic nervous system activates massively, triggering a surge in norepinephrine and dopamine that dwarfs what most pharmacological interventions achieve.
The study that launched a thousand cold plunge purchases: Søberg et al. [1], published in Cell Reports Medicine, studied 85 participants practicing winter swimming combined with sauna use. The cold exposure component produced a 250-530% increase in plasma norepinephrine that persisted for hours after exposure. Critically, the study also documented a sustained dopamine increase of approximately 250% — a finding that Andrew Huberman popularized on his podcast, driving much of the current interest.
This dopamine finding needs context. The 250% increase is comparable to what cocaine produces but through a completely different mechanism — cold triggers dopamine release via the locus coeruleus and sympathetic activation, not by blocking reuptake. Unlike stimulant drugs, the cold-induced dopamine elevation is gradual, sustained (lasting 2-3 hours), and doesn't produce the crash-and-craving cycle of dopamine reuptake inhibitors. This pharmacological profile is genuinely unusual and explains why regular cold exposure practitioners report stable mood elevation rather than the peaks and valleys of stimulant use.
Earlier foundational work by Šrámek et al. [2] had already demonstrated that cold water immersion at 14°C increased plasma norepinephrine by 530% and dopamine by 250% in young men — establishing the dose-response relationship between water temperature and catecholamine release. Colder temperatures produce larger responses, but the relationship plateaus: there appears to be minimal additional catecholamine benefit below approximately 10°C compared to the substantially increased discomfort and risk.
The Buijze Cold Shower RCT: The Largest Controlled Trial
The most methodologically rigorous cold exposure study to date is the Buijze et al. [3] trial published in PLOS ONE, conducted at the Academic Medical Center in Amsterdam. This was a pragmatic randomized controlled trial enrolling 3,018 participants — a sample size that gives it unusual statistical power for a lifestyle intervention study.
Participants were randomized to routine hot-to-cold showers (ending with 30, 60, or 90 seconds of cold water) or hot showers only (control) for 30 consecutive days. The primary outcome was self-reported sick days from work over the following 60 days. Key findings:
- 29% reduction in self-reported sick days in all cold shower groups compared to control (p<0.001)
- No significant difference between 30, 60, and 90 seconds — even brief cold exposure produced the full effect
- 54% of participants in the intervention group voluntarily continued cold showers after the study ended, suggesting subjective benefit
- The effect size was comparable to regular exercise in reducing sick days — a comparison the authors explicitly made
Limitations worth noting: the outcome was self-reported (not physician-verified illness), the study couldn't be blinded (participants knew whether they took cold showers), and the sick day reduction might reflect improved resilience/motivation rather than immune function per se. Still, n=3,018 with a significant primary outcome is hard to dismiss.
Cold Exposure and Depression: The Shevchuk Hypothesis
Shevchuk [4], published in Medical Hypotheses, proposed that adapted cold showers (gradually decreasing temperature to 20°C over the body for 2-3 minutes, preceded by a 5-minute gradual adaptation) could serve as a treatment for depression. The proposed mechanism: cold receptors in the skin send an overwhelming amount of electrical impulses from peripheral nerve endings to the brain, producing an antidepressive effect via activation of the locus coeruleus and sympathetic nervous system.
This was a hypothesis paper, not a clinical trial. However, subsequent research has provided supporting evidence. A 2023 case series by Massey et al. published in BMJ Case Reports documented cold-water swimming producing sustained remission from treatment-resistant depression in a 24-year-old woman who had failed multiple antidepressant medications. While case reports are low-level evidence, the neurochemical mechanism — sustained norepinephrine and dopamine elevation through a non-pharmacological pathway — is biologically coherent with antidepressant effects.
Brown Adipose Tissue Activation: The Metabolic Angle
Brown adipose tissue (BAT) is metabolically active fat that burns calories to generate heat. Adults retain varying amounts of BAT, primarily in the supraclavicular and cervical regions. Cold exposure is the most potent known activator of BAT.
Van der Lans et al. [5], published in the Journal of Clinical Investigation, demonstrated that 10 days of cold acclimation (6 hours daily at 15-16°C) increased BAT activity and non-shivering thermogenesis in healthy adults. Participants showed increased energy expenditure and improved cold tolerance without increased shivering — indicating genuine metabolic adaptation.
Yoneshiro et al. [5] in the Journal of Clinical Investigation showed that 6 weeks of cold exposure (2 hours daily at 17°C) significantly reduced body fat mass and increased BAT activity as measured by FDG-PET/CT scanning. The metabolic implications are real but modest: cold-activated BAT burns approximately 100-200 extra calories per day in most studies — meaningful over months but not the metabolic revolution some influencers claim.
A 2022 study by Becher et al. in Nature Medicine provided the most compelling evidence yet that BAT activity matters beyond thermogenesis, showing that BAT activation improves glucose homeostasis, lipid metabolism, and cardiometabolic health markers independent of weight loss — suggesting cold exposure's metabolic benefits may extend beyond simple calorie burning.
Post-Exercise Recovery: The Cochrane Evidence
Cold water immersion for athletic recovery is the oldest application and the most-studied. A 2012 Cochrane systematic review [6] analyzed 17 trials of cold water immersion for post-exercise recovery. The review found moderate-quality evidence that CWI reduces delayed-onset muscle soreness (DOMS) at 24, 48, 72, and 96 hours post-exercise compared to passive recovery.
However, a critical 2015 study by Roberts et al. in the Journal of Physiology complicated the recovery narrative: regular post-exercise cold water immersion attenuated long-term gains in muscle mass and strength compared to active recovery. Cold blunted the inflammatory signaling and satellite cell activity that drives muscle adaptation. The implication: cold plunges after strength training may feel good but reduce the training stimulus you're trying to create.
This finding hasn't penetrated the wellness mainstream, where cold plunges are marketed as universally beneficial for recovery. The science suggests a more nuanced picture: cold water immersion may benefit recovery from competitions or high-volume training blocks where performance matters more than adaptation, but may be counterproductive as a routine post-training protocol for athletes seeking strength or hypertrophy gains.
The Bottom Line on Studies
What's well-established: Cold exposure produces large, sustained catecholamine increases (dopamine, norepinephrine). Brown adipose tissue activation is real and measurable. Brief cold showers reduce self-reported sick days. Post-exercise cold reduces acute soreness. What's complicated: The recovery picture is more nuanced than influencers present — cold may help acute soreness while blunting long-term training adaptations. Depression benefits are mechanistically plausible but lack large RCTs. The metabolic calorie-burning claims are real but modest.
- 2021
- 2000
- 2016
- 2008
- 2013
- Bleakley et al.